Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.Bull World Health Organ. 2020 Sep 01; 98(9):588-589.BW
Abstract
Melanie Saville talks to Gary Humphreys about the specific challenges faced in developing and distributing SARS-CoV-2 vaccines and the need to fund end-to-end approaches to support those aims.
Links
MeSH
Pub Type(s)
News
Language
eng
PubMed ID
33012858
Citation
"Melanie Saville: the End-to-end Process Needed for a SARS-CoV-2 Vaccine." Bulletin of the World Health Organization, vol. 98, no. 9, 2020, pp. 588-589.
Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine. Bull World Health Organ. 2020;98(9):588-589.
(2020). Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine. Bulletin of the World Health Organization, 98(9), 588-589. https://doi.org/10.2471/BLT.20.030920
Melanie Saville: the End-to-end Process Needed for a SARS-CoV-2 Vaccine. Bull World Health Organ. 2020 Sep 1;98(9):588-589. PubMed PMID: 33012858.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.
PY - 2020/10/5/entrez
PY - 2020/10/6/pubmed
PY - 2020/10/21/medline
SP - 588
EP - 589
JF - Bulletin of the World Health Organization
JO - Bull World Health Organ
VL - 98
IS - 9
N2 - Melanie Saville talks to Gary Humphreys about the specific challenges faced in developing and distributing SARS-CoV-2 vaccines and the need to fund end-to-end approaches to support those aims.
SN - 1564-0604
UR - https://www.unboundmedicine.com/medline/citation/33012858/Melanie_Saville:_the_end_to_end_process_needed_for_a_SARS_CoV_2_vaccine_
DB - PRIME
DP - Unbound Medicine
ER -
Latest evidence on COVID-19 from PubMed, WHO, CDC.
Visit free Relief Central.
Visit free Relief Central.
Try the Free App:
